Whole-body [18F]FDG PET in the management of metastatic brain tumours

Acta Neurochirurgica

Volumn 140, Issue 7, 1998, Pages 665-674

  Kim, D G ^a   Kim, C Y ^a   Paek, S H ^a   Lee, D S ^a   Chung, J K ^a   Jung, H W ^a   Cho, B K ^a  

^a Seoul National University   (South Korea)

Author keywords

18F FDG (2 deoxy 2 18F fluoro D glucose); Brain; Metastasis; PET (positron emission tomography); Tumour

Indexed keywords

FLUORODEOXYGLUCOSE F 18; DIAGNOSTIC AGENT;

ADULT; AGED; ANGIOMA; ARTICLE; BRAIN LYMPHOMA; BRAIN METASTASIS; CANCER DIAGNOSIS; CLINICAL ARTICLE; CLINICAL TRIAL; COMPUTER; COMPUTER ASSISTED TOMOGRAPHY; COMPUTER PROGRAM; DEVICE; EWING SARCOMA; FEMALE; GLIOBLASTOMA; HISTOPATHOLOGY; HUMAN; LYMPH NODE BIOPSY; LYMPH NODE METASTASIS; MALE; NUCLEAR MAGNETIC RESONANCE IMAGING; POSITRON EMISSION TOMOGRAPHY; PRIORITY JOURNAL; SCINTISCANNING; WHOLE BODY SCINTISCANNING; BRAIN EDEMA; BRAIN TUMOR; COMPUTER ASSISTED EMISSION TOMOGRAPHY; DIFFERENTIAL DIAGNOSIS; GLUCOSE BLOOD LEVEL; METABOLISM; METASTASIS; MIDDLE AGED; NEUROLOGIC EXAMINATION; PATHOLOGY; SENSITIVITY AND SPECIFICITY;

ADULT; AGED; BLOOD GLUCOSE; BRAIN EDEMA; BRAIN NEOPLASMS; DIAGNOSIS, DIFFERENTIAL; FEMALE; FLUORODEOXYGLUCOSE F18; HUMANS; MAGNETIC RESONANCE IMAGING; MALE; MIDDLE AGED; NEUROLOGIC EXAMINATION; SENSITIVITY AND SPECIFICITY; TOMOGRAPHY, EMISSION-COMPUTED; TOMOGRAPHY, X-RAY COMPUTED;

EID: 0032239243     PISSN: 00016268     EISSN: None     Source Type: Journal    
DOI: 10.1007/s007010050161     Document Type: Article

References (36)

1. Bauet JW, Abemayor E, Jabour BA et al (1992) Positron emission tomography: A new, precise imaging modality for the detection of primary head and neck tumours and assessment of cervical adenopathy. Laryngoscope 102: 281-288
2. Beets G, Penniinckx F, Schiepers C et al (1994) Clinical value of whole-body positron emission tomography with [18F] fluorodeoxyglucose in recurrent colorectal cancers. Br J Surg 81: 1666-1670
3. Black KL (1996) Primary brain tumors: Aspects of imaging and functional localization, In: Wilkins RH, Rengachary SS (eds) Neurosurgery, 2nd edn, Vol 1. McGraw-Hill, New York, pp 729-734
4. Blasberg RG (1994) Prediction of brain tumour therapy response by PET. J Neurooncol 22: 281-286
5. Boni R, Boni RA, Steinert H et al (1995) Staging of metastatic melanoma by whole-body positron emission tomography using 2-fluorine-18-fluoro-2-deoxy-D-glucose. Br J Dermatol 132(4): 556-562
6. Braams JW, Prium J, Freling NJ et al, (1995) Detection of lymph node metastases of squamous cell cancer of the head and neck with FDG-PET and MRI. J Nucl Med 36: 211-216
7. 18F-FDG in brain tumours: A powerful diagnostic and prognostic tool. Invest Radiol 22: 360-372
8. 18F-FDG and positron emission tomography. Neurology (NY) 32: 1323-1329
9. Di Chiro G, Hatazawa J, Katz DA et al (1987) Glucose utilization by intracranial meningioma as an index of tumour aggressivity and probability of recurrence: A PET study. Radiology 164: 521-526
10. Galicich JH, Arbit E, Wronski M (1996) Metastatic brain tumours. In: Wilkins RH, Rengachary SS (eds) Neurosurgery Vol 1, 2nd edn. New York, McGraw-Hill, pp 807-821
11. 18F-FDG PET. Ann Neurol 29: 347-355
12. Hawkins RA, Hoh CK, Glaspy J et al (1992) The role of positron emission tomography in oncology and other whole-body applications. Semin Nucl Med 22: 268-284
13. Herholz K, Rudolf J, Heiss WD (1992) FDG transport and phosphorylation in human gliomas measured with dynamic PET. J Neurooncol 12: 159-165
14. Hoh CK, Hawkins RA, Glaspy JA et al (1993) Cancer detection with whole-body PET using 2-[18F] 2-deoxy-D-glucose. J Comput Assist Tomogr 17: 582-589
15. Hunter GJ, Choi NC, McLoud TC et al (1993) Lung tumor metastasis to the breast detected by fluorine-18-fluorodeoxyglucose PET. J Nucl Med 34: 1573-1581
16. Hutchinson M, Nenov V, Mazziotta JC (1996) Neurosurgical application of positron emission tomography. In: Youman JR (ed) Neurol Surg 4th edn, Vol 1. Saunders, Philadelphia, pp 172-184
17. 18F-FDG PET. Am J Radiol 163: 1459-1465
18. Karlan BY, Hoh CK, Tse NY et al (1993) Whole-body positron emission tomography with (fluorine-18)-2-deoxyglucose can detect metastatic carcinoma of the fallopian tube. Gynecol Oncol 49: 383-388
19. 18F-FDG uptake in primary cerebral lymphoma: A PET study. J Comput Assist Tomogr 12(1): 47-48
20. Laubenbacher C, Saimweber D, Manslau WC et al (1995) Comparison of flourine-18-fluorodeox-yglucose PET, MRI and endoscopy for staging of head and neck squamous cell carcinoma. J Nucl Med 36: 1747-1757
21. Ogawa T, Inugami A, Hatazawa J et al (1996) Clinical positron emission tomography for brain tumours: Comparison of fludeoxyglucose F 18 and L-methyl-C-methionine. Am J Neuroradiol 17:345-353
22. Patronas NJ, Di Chiro G, Kufta C et al (1985) Prediction of survival in glioma patients by means of positron emission tomography. J Neurosurg 62: 816-822
23. Roelcke U (1994) PET: Brain tumor biochemistry. J Neurooncol 22: 275-279
24. Rosenfeld SS, Hoffman JM, Coleman RE et al (1992) Studies of primary central nervous system lymphoma with fluorine-18-fluorodeoxyglucose positron emission tomography. J Nucl Med 33: 532-536
25. Sawaya R, Ligon BL, Bindal RK (1996) Clinical features and therapeutic decision making in metastatic brain tumours. In: Tindall GT, Cooper PR, Barrow DL (eds) The practice of neurosurgery Vol 1. Williams & Wilkins, Baltimore, pp 715-732
26. Scott WJ, Gobar LS, Hauser LG et al (1995) Detection of scalene lymph node metastases from lung cancer. Chest 107: 1174-1176
27. 18F]fluoro-D-glucose. Radiology 195(3): 705-709
28. Tse NY, Hoh CK, Hawkins RA et al (1992) The application of positron emission tomographic imaging with Fluorodeoxyglucose to the evaluation of breast disease. Ann Surg pp 27-34
29. 18F)-fluoro-D-glucose: Pilot animal and human studies. J Urol 146: 1470-1474
30. 18F]fluoro-D-glucose (FDG) for the detection of tumour involvement in lymph nodes. J Nucl Med 31: 1831-1835
31. Wahl RL, Quint LE, Greenough RL et al (1994) Staging of mediastinal non-small cell lung cacer with FDG PET, CT, and fusion images: Preliminary prospective evaluation. Radiology 191: 371-377
32. Weber G (1977) Enzymology of cancer cells (first of two parts). N Engl J Med 296: 486-493
33. Weber G (1977) Enzymology of cancer cells (second of two parts). N Engl J Med 296: 541-551
34. Yasuda S, Raja S, Hubner KF (1995) Application of whole-body positron emission tomography in the imaging of esophageal cancer: Report of a case. Jpn J Surg 25: 261-264
35. Young B, Patchell RA (1996) Brain métastases, In: Youman JR (ed) Neurological Surgery 4th edn, Vol 1. Saunders, Philadelphia, pp 2748-2760
36. Yung WK, Sagawa R, Curran WJ et al (1996) Intracranial metastatic central nervous tumours, In: Levin VA (ed) Cancer in the nervous system. Churchill Livingstone, New York, pp 243-258